Skip to content

FP7

EUROPAIN

Understanding chronic pain and improving its treatment

Programme
Seventh Framework Programme
Started
Ends
Duration
72 months
Total cost
EUR 22,550,083
EU contribution
EUR 6,229,343
Participants
24 from 7 countries
Topic
FP7_IMI-JU-01-2008-09
Grant agreement
115007

Coordinated by H. Lundbeck As (DKDenmark).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
H. Lundbeck AsDKDenmarkCoordinatorNot statedPIC (1.00)
Abbvie Deutschland GmbH & Co KGDEGermanyParticipantNot statedPIC (1.00)
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbHDEGermanyParticipantEUR 445,793known name (0.95)
Boehringer Ingelheim InternationalgmbhDEGermanyParticipantNot statedPIC (1.00)
Christian-Albrechts-Universitaet Zu KielDEGermanyParticipantEUR 425,871PIC (1.00)
Grunenthal GmbHDEGermanyParticipantNot statedPIC (1.00)
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainDEGermanyParticipantEUR 415,741PIC (1.00)
Klinikum der Technischen Universität München (Tum Klinikum)DEGermanyParticipantEUR 412,141known name (0.97)
Ruprecht-Karls-Universitaet HeidelbergDEGermanyParticipantEUR 436,430PIC (1.00)
Aarhus UniversitetshospitalDKDenmarkParticipantEUR 1,334,952known name (0.95)
Region HovedstadenDKDenmarkParticipantEUR 359,199known name (0.95)
Syddansk UniversitetDKDenmarkParticipantEUR 209,726known name (0.95)
Esteve Pharmaceuticals, SAESSpainParticipantNot statedPIC (1.00)
Neuroscience Technologies SlpESSpainParticipantEUR 98,364PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantNot statedPIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantNot statedPIC (1.00)
Imperial College of Science Technology and MedicineGBUnited KingdomParticipantEUR 532,852PIC (1.00)
King's College LondonGBUnited KingdomParticipantEUR 402,298known name (0.95)
Neuroscience Technologies LimitedGBUnited KingdomParticipantEUR 12,000PIC (1.00)
The Chancellor, Masters and Scholars of the University of OxfordGBUnited KingdomParticipantEUR 383,409PIC (1.00)
University College LondonGBUnited KingdomParticipantEUR 760,567known name (0.95)
Astellas Pharma Europe BVNLNetherlandsParticipantNot statedPIC (1.00)
Astrazeneca ABSESwedenParticipantNot statedPIC (1.00)

Changes of the consortium

First seen on with 24 participants from 7 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.